Evidence map›Paper›PMID 25192051›Full record

ArticleJournal of neuropathology and experimental neurology2014

Aberrant production of tenascin-C in globoid cell leukodystrophy alters psychosine-induced microglial functions.

Kumiko I Claycomb, Paige N Winokur, Kasey M Johnson, Alexandra M Nicaise, Anthony W Giampetruzzi, Anthony V Sacino, Evan Y Snyder, Elisa Barbarese, Ernesto R Bongarzone, Stephen J Crocker

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Article
  15. Review
  16. Neuroimmune mechanisms in Krabbe's disease.Journal of neuroscience research · 2016
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Kumiko I ClaycombFrom the Department of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut (KIC, PNW, KMJ, AMN, AWG, AVS, EB, SJC); Stem Cells and Regenerative Biology Program, Sanford-Burnham Institute, La Jolla, California (EYS); and Department of Anatomy and Cell Biology, University of Illinois, Chicago, Illinois (ERB).
Paige N Winokur
Kasey M Johnson
Alexandra M Nicaise
Anthony W Giampetruzzi
Anthony V Sacino
Evan Y Snyder
Elisa Barbarese
Ernesto R Bongarzone
Stephen J Crocker
UConn Health · USSanford Burnham Prebys Medical Discovery Institute · USUniversity of Illinois Chicago · US

Funding

Combined Neuroprotection and Metabolic Correction to Treat LeukodystrophiesR01NS065808 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONGARZONE, ERNESTO ROQUE · 2009 to 2018
$3.0M
Development of a conditional T1MP-1 knockout mouseR03NS078392 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI CROCKER, STEPHEN J · 2012 to 2013
$151k
NICHD NIH HHS N01-HD-9-0011NINDS NIH HHS NS078392NINDS NIH HHS R01 NS065808NINDS NIH HHS R03 NS078392PHS HHS RNS065808A
6 · The paper itself

Abstract

Globoid cell leukodystrophy (GLD), or Krabbe disease, is a rare and often fatal demyelinating disease caused by mutations in the galactocerebrosidase (galc) gene that result in accumulation of galactosylsphingosine (psychosine). We recently reported that the extracellular matrix (ECM) protease, matrix metalloproteinase-3, is elevated in GLD and that it regulates psychosine-induced microglial activation. Here, we examined central nervous system ECM component expression in human GLD patients and in the twitcher mouse model of GLD using immunohistochemistry. The influence of ECM proteins on primary murine microglial responses to psychosine was evaluated using ECM proteins as substrates and analyzed by quantitative real-time polymerase chain reaction, immunocytochemistry, and ELISA. Functional analysis of microglial cytotoxicity was performed on oligodendrocytes in coculture, and cell death was measured by lactose dehydrogenase assay. Tenascin-C (TnC) was expressed at higher levels in human GLD and in twitcher mice versus controls. Microglial responses to psychosine were enhanced by TnC, as determined by an increase in globoid-like cell formation, matrix metalloproteinase-3 mRNA expression, and higher toxicity toward oligodendrocytes in culture. These findings were consistent with a shift toward the M1 microglial phenotype in TnC-grown microglia. Thus, elevated TnC expression in GLD modified microglial responses to psychosine. These data offer a novel perspective and enhance understanding of the microglial contribution to GLD pathogenesis.

Indexed as

AnimalsAnimals, NewbornCells, CulturedChild, PreschoolCoculture TechniquesHumansInfantLeukodystrophy, Globoid CellMiceMice, Inbred C57BLMicrogliaPsychosineTenascinPsychosineTenascin

Identifiers

PMID25192051
PMCPMC4169335
OpenAlexW2090563866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.